Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Multiples Myelom: CD38-Antikörper: Etablierte und künftige Therapiesäulen | Im Fokus
Human CD38 Antibody AF2404: R&D Systems
Ulrich Seybold's research works | Ludwig-Maximilians-University of Munich, Munich (LMU) and other places
CD38 Antibody (HIT2) (NB500-510): Novus Biologicals
Investment Hypothese: Fate Therapeutics | 10xDNA
CD38 Antibody (HIT2) (NB500-510): Novus Biologicals
CD38 | SpringerLink
Basic principles of replication and immunology of SARS-CoV-2]. - Abstract - Europe PMC
CD38 Antibody (HIT2) (NB500-510): Novus Biologicals